Search

Bruce Carleton

Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
Integrating disease and drug related phenotypes for improved identification of pharmacogenomic variants
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
Analyses of adverse drug reactions-nationwide active surveillance network: Canadian Pharmacogenomics Network for Drug Safety database
Genome-Wide Association Studies of drug-induced liver injury make progress beyond the HLA region
Outcome definition influences the relationship between genetic polymorphisms of ERCC1, ERCC2, SLC22A2 and cisplatin nephrotoxicity in adult testicular cancer patients
Pharmacogenomics of cisplatin-induced ototoxicity: Successes, shortcomings, and future avenues of research
Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients
Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer

Powered by the Academic theme for Hugo.